Kinsa, the company behind the world’s first app-enabled, FDA-approved smart thermometer, has today announced the close of a $9.6 million Series A financing round with participation from Kleiner Perkins Caufield & Byers, FirstMark Capital, and Andy Palmer, among others. This comes directly on the heels of the launch of a new program called Fluency, which lets Kinsa track the spread… Read More

See the original article here:
Kinsa Raises $9.6M Series A For A Smart Thermometer That Tracks The Spread Of Illness